# Autobio Diagnostics

> Autobio Diagnostics is a VC fund in Zhengzhou backing Medical Device and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Zhengzhou, China
- Total investments: 3
- Last investment: Dec 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/autobio-diagnostics/about/
- Website: http://www.autobio.com.cn/en/

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 2 | 67% |
| Medical | 1 | 33% |
| Industrial | 1 | 33% |
| Health Care | 1 | 33% |
| Manufacturing | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SpaceGen | SpaceGen is dedicated to providing innovative services for individualized precision medical testing of tumors. |  | Venture - Series Unknown | Dec 31, 2025 |  |
| Meili Technology | Meili Technology has independently created commercial gene sequencing instruments and supporting reagents with ultra-long read length, no amplification, quick, accuracy, and low cost, with the goal of opening up the product closed loop from sample preparation to report generation. |  | Series A | Feb 15, 2023 |  |
| CORUI | CORUI manufactures and develops chromatographic instruments. Its instruments offer high accuracy, high speed, and low-cost operations, enabling customers to cut costs and improve operational efficiency. |  | Series A | Jun 09, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Future Capital Discovery Fund](https://shizune.co/investors/profile/futurecap-e45d) — VC Fund, 1 deal together
- Shanghai Yinyu Investment Management Center — VC Fund, 1 deal together
- [Topping Capital](https://shizune.co/investors/profile/topping-capital-77fc) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Autobio Diagnostics invest in?

Autobio Diagnostics invests primarily in Medical Device, Medical and Industrial startups, most often at Series A and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Autobio Diagnostics last invest?

The most recent investment recorded for Autobio Diagnostics closed in Dec 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co